Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on AON-D21 for Patients with Severe Community-Acquired Pneumonia in Intensive Care
BelgiumStudy on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma
BelgiumStudy on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes
BelgiumStudy of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
BelgiumStudy on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
BelgiumStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
BelgiumStudy on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis
BelgiumStudy on Elinzanetant for Treating Hot Flashes in Women with or at High Risk for Hormone-Receptor Positive Breast Cancer
BelgiumStudy of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)
BelgiumStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
BelgiumStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
BelgiumStudy of Amivantamab with Carboplatin and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutation
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
